SEC Form 5 · accession 0001237899-17-000014
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Yancopoulos
Officer — President & CSO · Director
Period of report
Dec 31, 2016
Accepted (ET)
Feb 10, 2017 · 8:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 20, 2016 | G | 1,105 | $0.00 | D | 66,871 | I | by Trust |
| Common Stock | Dec 20, 2016 | G | 1,071 | $0.00 | D | 65,800 | I | by Trust |
| Common Stock | Dec 20, 2016 | G | 670 | $0.00 | D | 65,130 | I | by Trust |
| Common Stock | Dec 20, 2016 | G | 536 | $0.00 | D | 64,594 | I | by Trust |
| Common Stock | Dec 20, 2016 | G | 536 | $0.00 | D | 64,058 | I | by Trust |
| Common Stock | holding | — | — | — | 591,348 | D | ||
| Common Stock | holding | — | — | — | 500,000 | I | by GRAT | |
| Common Stock | holding | — | — | — | 5,676 | I | By 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.